Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

Bloomberg News reports that “Novartis AG (NOVN) entered a collaboration with Regenerex LLC, gaining access to stem cell technology that may help kidney transplant patients avoid taking anti-rejection medicine for life.” The pills that...
An article in the Boston Globe reports that minorities are less likely to receive a bone marrow donation than Caucasians in the United States. Asian Americans and African Americans have the most difficulty because they often have unique leukocyte...

Reuters Health • The Doctor's Channel Daily Newscast

Outcomes Good with Chemo-Hyperthermia for Refractory Germ-Cell Tumors

NEW YORK (Reuters Health) – Chemotherapy given in conjunction with regional hyperthermia produces good response rates in children and adolescents with refractory or recurrent germ-cell tumors, German researchers report “This protocol allows clinicians...